proxyvotesnow.com

Home › Asset managers › UBS › 2023-2024 › Against the board

UBS 2023-2024: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal UBS voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

2,187 proposals.

UBS, 2023-2024 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see how we count these.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedUBS votedFunds
HERITAGE COMMERCE CORP. May 23, 2024 Approval of the advisory proposal on 2023 executive compensation. Say-on-Pay Board (inferred) AGAINST 4
HEXCEL CORP. May 2, 2024 Advisory non-binding vote to approve 2023 executive compensation. Say-on-Pay Board (inferred) AGAINST 4
HILLMAN SOLUTIONS CORP. June 7, 2024 Approve, by non-binding vote, the compensation of our named executive officers; Say-on-Pay Board (inferred) AGAINST 4
HILTON GRAND VACATIONS INC. May 8, 2024 Approve by non-binding vote the compensation paid to the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
HIMS & HERS HEALTH INC. June 6, 2024 Advisory approval of the Company's executive compensation. Say-on-Pay Board (inferred) AGAINST 4
HNI CORP. May 16, 2024 Advisory vote to approve Named Executive Officer compensation Say-on-Pay Board (inferred) AGAINST 4
HOPE BANCORP INC. May 23, 2024 Approval, on an advisory and non-binding basis, to approve the 2023 compensation paid to the Company's "Named Executive Officers". Say-on-Pay Board (inferred) AGAINST 4
HORACE MANN EDUCATORS CORP. May 22, 2024 Approve the advisory resolution to approve Named Executive Officers' compensation, Say-on-Pay Board (inferred) AGAINST 4
HUB GROUP INC. May 23, 2024 Advisory vote to approve executive compensation. Say-on-Pay Board (inferred) AGAINST 4
HYSTER-YALE MATERIALS HANDLING INC. May 8, 2024 To approve on an advisory basis the Company's Named Executive Officer compensation Say-on-Pay Board (inferred) AGAINST 4
ICF INTERNATIONAL INC. June 7, 2024 ADVISORY VOTE REGARDING ICF INTERNATIONAL'S OVERALL PAY-FOR-PERFORMANCE NAMED EXECUTIVE OFFICER COMPENSATION PROGRAM. Approve by non-binding, advisory vote, the Company's overall pay-for-performance executive compensation program, as described in the Compensation Discussion and Analysis, the compensation tables and the related narratives and other materials in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 4
IMAX CORP. June 6, 2024 Advisory Vote on Named Executive Officer Compensation Approval, on an advisory basis, of the compensation of the Company's Named Executive Officers as set forth in the accompanying Proxy Circular and Proxy Statement. Say-on-Pay Board (inferred) AGAINST 4
IMMUNOGEN INC. January 31, 2024 A proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to ImmunoGen's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement; and Say-on-Pay Board (inferred) AGAINST 4
INARI MEDICAL INC. April 24, 2024 To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
INDEPENDENT BANK CORP. April 23, 2024 Approval of an advisory (non-binding) resolution to approve the compensation paid to our executives. Say-on-Pay Board (inferred) AGAINST 4
INDEPENDENT BANK CORP. May 16, 2024 Approve, on an advisory basis, the compensation of our named executive officers Say-on-Pay Board (inferred) AGAINST 4
INDEPENDENT BANK GROUP INC. June 11, 2024 ADVISORY APPROVAL OF SAY-ON-PAY: A (non-binding) vote regarding the compensation of the Company's named executive officers (Say-On-Pay). Say-on-Pay Board (inferred) AGAINST 4
INDIE SEMICONDUCTOR INC. June 13, 2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's Proxy Statement. Say-on-Pay Board (inferred) AGAINST 4
INGLES MARKETS INC. February 13, 2024 To approve, by non-binding vote, executive compensation, as disclosed in the Proxy Statement. Say-on-Pay Board (inferred) AGAINST 4
INGREDION INC. May 15, 2024 To approve, by advisory vote, the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
INHIBRX INC. May 24, 2024 To approve, by non-binding, advisory vote, certain compensation that may become payable to the Company's named executive officers in connection with the transactions contemplated by the Merger Agreement and Distribution Agreement. Say-on-Pay Board (inferred) AGAINST 4
INNOSPEC INC. May 10, 2024 Say on Pay - An advisory vote on the approval of executive compensation Say-on-Pay Board (inferred) AGAINST 4
INNOVIVA INC. June 17, 2024 Approval of a non-binding advisory resolution regarding executive compensation. Say-on-Pay Board (inferred) AGAINST 4
INSIGHT ENTERPRISES INC. May 21, 2024 To approve, on an advisory basis, named executive officer compensation; Say-on-Pay Board (inferred) AGAINST 4
INSPIRE MEDICAL SYSTEMS INC. May 2, 2024 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
INSTALLED BUILDING PRODUCTS INC. May 23, 2024 Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
INTEGRA LIFESCIENCES HOLDINGS CORP. May 9, 2024 To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
INTEGRAL AD SCIENCE HOLDING CORP. May 7, 2024 Approval, on an advisory (non-binding) basis, of the compensation of the Company's Named Executive Officers ("Say-on-Pay"). Say-on-Pay Board (inferred) AGAINST 4
INTELLIA THERAPEUTICS INC. June 12, 2024 Approve, on a non-binding advisory basis, the compensation of the named executive officers. Say-on-Pay Board (inferred) AGAINST 4
INTERDIGITAL INC. June 5, 2024 Advisory resolution to approve executive compensation. Say-on-Pay Board (inferred) AGAINST 4
IONIS PHARMACEUTICALS INC. June 6, 2024 To make an advisory vote on executive compensation. Say-on-Pay Board (inferred) AGAINST 4
IONQ INC. June 5, 2024 To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). Say-on-Pay Board (inferred) AGAINST 4
IOVANCE BIOTHERAPEUTICS INC. June 11, 2024 To approve, by non-binding advisory vote, the compensation of our named executive officers; Say-on-Pay Board (inferred) AGAINST 4
IRADIMED CORP. June 20, 2024 To approve, on a non-binding advisory basis, the compensation of the named executive officers; Say-on-Pay Board (inferred) AGAINST 4
IRHYTHM TECHNOLOGIES INC. May 29, 2024 To approve, on a non-binding advisory basis, the named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 4
JACK IN THE BOX INC. March 1, 2024 Advisory Vote to Approve Executive Compensation. Say-on-Pay Board (inferred) AGAINST 4
JANUS INTERNATIONAL GROUP INC. June 24, 2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
JEFFERIES FINANCIAL GROUP INC. March 28, 2024 Advisory vote to approve 2023 executive-compensation program. Say-on-Pay Board (inferred) AGAINST 4
JELD-WEN HOLDING INC. April 25, 2024 To approve, by non-binding advisory vote, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
JETBLUE AIRWAYS CORP. May 17, 2024 To approve, on an advisory basis, the compensation of our named executive officers Say-on-Pay Board (inferred) AGAINST 4
JOHN WILEY & SONS INC. September 28, 2023 Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
KADANT INC. May 15, 2024 To approve, by non-binding advisory vote, our executive compensation. Say-on-Pay Board (inferred) AGAINST 4
KARUNA THERAPEUTICS INC. March 12, 2024 To approve, on an advisory, non-binding basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger of Merger Sub with and into Karuna pursuant to the merger agreement. Say-on-Pay Board (inferred) AGAINST 4
KB HOME April 18, 2024 Advisory vote to approve named executive officer compensation Say-on-Pay Board (inferred) AGAINST 4
KEROS THERAPEUTICS INC. May 30, 2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement. Say-on-Pay Board (inferred) AGAINST 4
KFORCE INC. April 24, 2024 Advisory vote on Kforce's executive compensation. Say-on-Pay Board (inferred) AGAINST 4
KINETIK HOLDINGS INC. May 20, 2024 Approval of a non-binding resolution regarding the compensation of named executive officers for 2023 (say-on-pay). Say-on-Pay Board (inferred) AGAINST 4
KINSALE CAPITAL GROUP INC. May 23, 2024 Advisory vote to approve executive compensation Say-on-Pay Board (inferred) AGAINST 4
KIRBY CORP. April 26, 2024 Advisory vote on the approval of the compensation of Kirby's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
KKR REAL ESTATE FINANCE TRUST INC. April 19, 2024 Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
KNIFE RIVER CORP. May 14, 2024 Advisory Vote to Approve the Compensation Paid to the Company's Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 4
KRATOS DEFENSE & SECURITY SOLUTIONS INC. May 21, 2024 An advisory vote to approve the compensation of the Company's named executive officers, as presented in the proxy statement. Say-on-Pay Board (inferred) AGAINST 4
KRONOS WORLDWIDE INC. May 15, 2024 Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 4
KRYSTAL BIOTECH INC. May 17, 2024 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay Board (inferred) AGAINST 4
KURA ONCOLOGY INC. June 5, 2024 Approval, on an advisory basis, of the compensation of our named executive officers during the year ended December 31, 2023. Say-on-Pay Board (inferred) AGAINST 4
LADDER CAPITAL CORP. June 6, 2024 Approval of a non-binding, advisory resolution to approve our executive compensation ("Say on Pay"). Say-on-Pay Board (inferred) AGAINST 4
LANDSTAR SYSTEM INC. May 7, 2024 Advisory vote to approve executive compensation. Say-on-Pay Board (inferred) AGAINST 4
LANTHEUS HOLDINGS INC. April 25, 2024 The approval, on an advisory basis, of the compensation paid to our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LEGALZOOM.COM INC. June 6, 2024 An advisory vote on the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LEMAITRE VASCULAR INC. June 3, 2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LEMONADE INC. June 5, 2024 To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LESLIE'S INC. March 15, 2024 Non-binding, advisory vote to approve named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 4
LEVI STRAUSS & CO. April 24, 2024 Advisory vote to approve executive compensation. Say-on-Pay Board (inferred) AGAINST 4
LGI HOMES INC. April 25, 2024 Advisory vote to approve the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LIBERTY MEDIA CORP. June 10, 2024 The say-on-pay proposal, to approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LIFESTANCE HEALTH GROUP INC. June 3, 2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers; Say-on-Pay Board (inferred) AGAINST 4
LIGAND PHARMACEUTICALS INC. June 14, 2024 Approval, on an advisory basis, of the compensation of the named executive officers Say-on-Pay Board (inferred) AGAINST 4
LIGHTWAVE LOGIC INC. May 22, 2024 Advisory vote on executive compensation. Say-on-Pay Board (inferred) AGAINST 4
LINCOLN ELECTRIC HOLDINGS INC. April 19, 2024 To approve, on an advisory basis, the compensation of our named executive officers (NEOs). Say-on-Pay Board (inferred) AGAINST 4
LINDBLAD EXPEDITIONS HOLDINGS INC. June 4, 2024 The approval, on an advisory basis, of the 2023 compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LITTELFUSE INC. April 25, 2024 Approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LIVE OAK BANCSHARES INC. May 21, 2024 Say-on-Pay Vote. Non-binding, advisory proposal to approve compensation paid to our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LUMENTUM HOLDINGS INC. November 17, 2023 To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
LUMINAR TECHNOLOGIES INC. June 5, 2024 Approve, on an advisory (non-binding) basis, the compensation of Luminar Technologies, Inc.'s named executive officers. Say-on-Pay Board (inferred) AGAINST 4
M/I HOMES INC. May 13, 2024 A non-binding, advisory resolution to approve the compensation of the named executive officers of M/I Homes, Inc. Say-on-Pay Board (inferred) AGAINST 4
MAGNITE INC. June 12, 2024 To approve, on an advisory basis, of the compensation of the company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
MANITOWOC COMPANY INC. May 7, 2024 An advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
MARAVAI LIFESCIENCES HOLDINGS INC. May 23, 2024 To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers, and Say-on-Pay Board (inferred) AGAINST 4
MARCUS & MILLICHAP INC. May 2, 2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay Board (inferred) AGAINST 4
MARCUS CORP. May 23, 2024 To approve, by advisory vote, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
MARQETA INC. June 13, 2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
MARRIOTT VACATIONS WORLDWIDE CORP. May 10, 2024 Advisory vote to approve named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 4
MASTERBRAND INC. June 5, 2024 Advisory resolution to approve executive compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
MATERION CORP. May 9, 2024 To approve, by non-binding vote, named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 4
MATIV HOLDINGS INC. April 24, 2024 Approve, on an advisory basis, the Company's executive compensation. Say-on-Pay Board (inferred) AGAINST 4
MATTERPORT INC. June 10, 2024 To conduct an advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay Board (inferred) AGAINST 4
MAXLINEAR INC. May 23, 2024 To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2023. Say-on-Pay Board (inferred) AGAINST 4
MDU RESOURCES GROUP INC. May 14, 2024 Advisory Vote to Approve the Compensation Paid to the Company's Named Executive Officers. Say-on-Pay Board (inferred) AGAINST 4
MERCANTILE BANK CORP. May 23, 2024 Advisory vote to approve the compensation of our named executive officers disclosed in this proxy statement. Say-on-Pay Board (inferred) AGAINST 4
MERIT MEDICAL SYSTEMS INC. May 15, 2024 Approval of a non-binding, advisory resolution approving the compensation of the Company's named executive officers as described in the Merit Medical Systems, Inc. Proxy Statement. Say-on-Pay Board (inferred) AGAINST 4
MERITAGE HOMES CORP. May 16, 2024 Advisory vote to approve compensation of the Company's Named Executive Officers ("Say on Pay"). Say-on-Pay Board (inferred) AGAINST 4
MESA LABORATORIES INC. August 25, 2023 To approve, on an advisory basis, the Company's named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 4
METROPOLITAN BANK HOLDING CORP. May 29, 2024 Advisory Vote on Named Executive Officer Compensation for 2023 Say-on-Pay Board (inferred) AGAINST 4
MGP INGREDIENTS INC. May 23, 2024 Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay Board (inferred) AGAINST 4
MICROSOFT CORP. December 7, 2023 Report on Data Operations in Human Rights Hotspots Human Rights or Human Capital/workforce Shareholder Against FOR 4
MIDDLEBY CORP. May 14, 2024 Approval, on an advisory basis, of the compensation of our named executive officers; and Say-on-Pay Board (inferred) AGAINST 4
MIDDLESEX WATER CO. May 21, 2024 To provide a non-binding advisory vote to approve named executive officer compensation. Say-on-Pay Board (inferred) AGAINST 4
MIDLAND STATES BANCORP INC. May 6, 2024 To approve, on a non-binding, advisory basis, the compensation of certain executive officers, which we refer to as the "say-on-pay proposal." Say-on-Pay Board (inferred) AGAINST 4
MIMEDX GROUP INC. June 5, 2024 Advisory approval of executive compensation. Say-on-Pay Board (inferred) AGAINST 4
MIRATI THERAPEUTICS INC. December 13, 2023 To approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its named executive officers in connection with the Merger. Say-on-Pay Board (inferred) AGAINST 4

← Previous Page 7 of 22 Next →

← Back to UBS 2023-2024 overview

Built November 7, 2026 from SEC Form N-PX filings.